Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

10x Genomics (TXG) Return on Capital Employed (2019 - 2025)

10x Genomics' Return on Capital Employed history spans 7 years, with the latest figure at 0.07% for Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 17.0% year-over-year to 0.07%; the TTM value through Dec 2025 reached 0.07%, up 17.0%, while the annual FY2025 figure was 0.07%, 16.0% up from the prior year.
  • Return on Capital Employed for Q4 2025 was 0.07% at 10x Genomics, up from 0.11% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.06% in Q4 2021 and bottomed at 0.64% in Q1 2021.
  • The 5-year median for Return on Capital Employed is 0.21% (2023), against an average of 0.25%.
  • The largest YoY upside for Return on Capital Employed was 56bps in 2021 against a maximum downside of -55bps in 2021.
  • A 5-year view of Return on Capital Employed shows it stood at 0.06% in 2021, then crashed by -226bps to 0.19% in 2022, then plummeted by -68bps to 0.32% in 2023, then increased by 25bps to 0.24% in 2024, then surged by 71bps to 0.07% in 2025.
  • Per Business Quant, the three most recent readings for TXG's Return on Capital Employed are 0.07% (Q4 2025), 0.11% (Q3 2025), and 0.12% (Q2 2025).